Investor Alert

Nuvation Bio Inc.

NYS: NUVB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/220091137/composite

$

9.40

Change

0.00 0.00%

Volume

Volume 12,168

Oct 21, 2021, 4:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/220091137/composite

Today's close

$ 9.38

$ 9.40

Change

+0.02 +0.21%

Day low

Day high

$9.32

$9.50

Open
Open: 9.40

52 week low

52 week high

$7.66

$15.23

Open

Market cap

$2.05B

Average volume

657,702

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.65

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nuvb

MarketWatch News on NUVB

  1. Nuvation Bio started at outperform with $16 stock price target at BMO Capital

    11:22 a.m. March 8, 2021

    - Tomi Kilgore

  2. Nuvation Bio started at outperform with $20 stock price target at Wedbush

    8:28 a.m. March 8, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/nuvb

Other News on NUVB

  1. 4 Stocks Seth Klarman and David Abrams Both Own

    2:31 p.m. Sept. 28, 2021

    - GuruFocus.com

  2. Tracking Seth Klarman's Baupost Group Holdings - Q2 2021 Update

    9:17 p.m. Aug. 15, 2021

    - Seeking Alpha

  3. Panacea Acquisition II prices $150M SPAC IPO in biotech space

    9:15 a.m. April 7, 2021

    - Seeking Alpha

  4. Nuvation Bio's NUV-422 wins FDA 'Orphan Drug' status

    9:00 a.m. March 11, 2021

    - Seeking Alpha

  5. 10-Q: PANACEA ACQUISITION CORP

    11:08 a.m. Nov. 16, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Investors Pump Billions into Biotech Startups

    10:06 a.m. Oct. 22, 2020

    - The Wall Street Journal Interactive Edition

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.